Friday, August 1, 2008

HSA - summary

7208580

Atomic structure of the hemalbumin complex and its use in designing therapeutic compounds
A high resolution structure of the hemalbumin binding complex is provided which includes the detailed atomic coordinates which reflect the binding site and the binding characteristics of the...

US20050182246

Atomic structure of the hemalbumin complex and its use in designing therapeutic
A high resolution structure of the hemalbumin binding complex is provided which includes the detailed atomic coordinates which reflect the binding site and the binding characteristics of the...

WO/2003/074128A2

ATOMIC STRUCTURE OF THE HEMALBUMIN COMPLEX AND ITS USE IN DESIGNING THERAPEUTIC COMPOUNDS
A high resolution structure of the hemalbumin binding complex is provided which includes the detailed atomic coordinates which reflect the binding site and the binding characteristics of the...

5585466

Crystals of serum albumin for use in genetic engineering and rational drug design
Serum albumin crystal forms have been produced which exhibit superior x-ray diffraction quality. The crystals are produced from both recombinant and wild-type human serum albumin, canine, and...

EP0357857B1

Human serum albumin crystals and method of preparation
Abstract of EP0357857 HSA crystals are provided in the form of tetragonal plates having the space groups P4212, the crystals being grown to sizes in excess of 0.5 mm in two dimensions and a...

EP0357857A1

Human serum albumin crystals and method of preparation.
HSA crystals are provided in the form of tetragonal plates having the space groups P4212, the crystals being grown to sizes in excess of 0.5 mm in two dimensions and a thickness of 0.1 mm. Growth...

4833233

Human serum albumin crystals and method of preparation
HSA crystals are provided in the form of tetragonal plates having the space groups P42 1 2, the crystals being grown to sizes in excess of 0.5 mm in two dimensions and a thickness of 0.1 mm....

July 2008 publications

7400979

Method of identifying inhibitors of Lck
The present invention relates to polypeptides which comprise the ligand binding domain of Lck, crystalline forms of these polypeptides, and the use of these crystalline forms to determine the three...

US20080167385

Crystal Structure of Human Proliferating Cell Nuclear Antigen (Pcna) and Uses Thereof
The present invention relates to crystals comprising human PCNA, and methods and assays for designing and identifying small molecule PCNA inhibitors using said crystals.